Bellevue Group’s Biomea Fusion BMEA Stock Holding History

Bellevue Group’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,800	Closed	-$266K	–	168
2024 Q1	$266K	Sell	17,800 -7,200	-29%	-$119K	﹤0.01%	150
2023 Q4	$363K	Buy	+25,000	New	+$304K	0.01%	141

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bellevue Group's BMEA Position: Q2 2024 in Review

Bellevue Group sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 17,800 shares — an estimated $266K sold.

Bellevue Group first reported a position in BMEA in Q4 2023 and held it in 2 quarters. The position peaked at $363K in Q4 2023. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

Bellevue Group reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
Bellevue Group sold 17,800 Biomea Fusion shares in Q2 2024, an estimated $266K.
Bellevue Group first reported a position in Biomea Fusion in Q4 2023 and held it in 2 quarters.
Bellevue Group's Biomea Fusion position peaked at $363K in Q4 2023.
107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on Bellevue Group's 13F filing for Q2 2024, filed 14 Aug 2024.